A drug with the SMILES CC(Sc1nn(-c2ccc(F)cc2)c(=S)s1)C(=O)c1c(N)n(C)c(=O)n(C)c1=O has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 15.515\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(Sc1nn(-c2ccc(F)cc2)c(=S)s1)C(=O)c1c(N)n(C)c(=O)n(C)c1=O
CC(Sc1nn(-c2ccc(F)cc2)c(=S)s1)C(=O)c1c(N)n(C)c(=O)n(C)c1=O
6-amino-5-[2-[[4-(4-fluorophenyl)-5-sulfanylidene-1,3,4-thiadiazol-2-yl]sulfanyl]propanoyl]-1,3-dimethylpyrimidine-2,4-dione